Matthew P Banegas1, Esther M John2, Martha L Slattery3, Scarlett Lin Gomez2, Mandi Yu4, Andrea Z LaCroix5, David Pee6, Rowan T Chlebowski7, Lisa M Hines8, Cynthia A Thompson9, Mitchell H Gail10. 1. Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA. 2. Cancer Prevention Institute of California, Fremont, CA, USA. 3. University of Utah, Department of Medicine, Salt Lake City, UT, USA. 4. Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA. 5. Division of Epidemiology, Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, USA. 6. Information Management Services, Rockville, MD, USA. 7. Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. 8. Department of Biology, University of Colorado Colorado Springs, Colorado Springs, CO, USA. 9. Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA. 10. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
Abstract
Background: There is no model to estimate absolute invasive breast cancer risk for Hispanic women. Methods: The San Francisco Bay Area Breast Cancer Study (SFBCS) provided data on Hispanic breast cancer case patients (533 US-born, 553 foreign-born) and control participants (464 US-born, 947 foreign-born). These data yielded estimates of relative risk (RR) and attributable risk (AR) separately for US-born and foreign-born women. Nativity-specific absolute risks were estimated by combining RR and AR information with nativity-specific invasive breast cancer incidence and competing mortality rates from the California Cancer Registry and Surveillance, Epidemiology, and End Results program to develop the Hispanic risk model (HRM). In independent data, we assessed model calibration through observed/expected (O/E) ratios, and we estimated discriminatory accuracy with the area under the receiver operating characteristic curve (AUC) statistic. Results: The US-born HRM included age at first full-term pregnancy, biopsy for benign breast disease, and family history of breast cancer; the foreign-born HRM also included age at menarche. The HRM estimated lower risks than the National Cancer Institute's Breast Cancer Risk Assessment Tool (BCRAT) for US-born Hispanic women, but higher risks in foreign-born women. In independent data from the Women's Health Initiative, the HRM was well calibrated for US-born women (observed/expected [O/E] ratio = 1.07, 95% confidence interval [CI] = 0.81 to 1.40), but seemed to overestimate risk in foreign-born women (O/E ratio = 0.66, 95% CI = 0.41 to 1.07). The AUC was 0.564 (95% CI = 0.485 to 0.644) for US-born and 0.625 (95% CI = 0.487 to 0.764) for foreign-born women. Conclusions: The HRM is the first absolute risk model that is based entirely on data specific to Hispanic women by nativity. Further studies in Hispanic women are warranted to evaluate its validity. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.
Background: There is no model to estimate absolute invasive breast cancer risk for Hispanic women. Methods: The San Francisco Bay Area Breast Cancer Study (SFBCS) provided data on Hispanic breast cancer case patients (533 US-born, 553 foreign-born) and control participants (464 US-born, 947 foreign-born). These data yielded estimates of relative risk (RR) and attributable risk (AR) separately for US-born and foreign-born women. Nativity-specific absolute risks were estimated by combining RR and AR information with nativity-specific invasive breast cancer incidence and competing mortality rates from the California Cancer Registry and Surveillance, Epidemiology, and End Results program to develop the Hispanic risk model (HRM). In independent data, we assessed model calibration through observed/expected (O/E) ratios, and we estimated discriminatory accuracy with the area under the receiver operating characteristic curve (AUC) statistic. Results: The US-born HRM included age at first full-term pregnancy, biopsy for benign breast disease, and family history of breast cancer; the foreign-born HRM also included age at menarche. The HRM estimated lower risks than the National Cancer Institute's Breast Cancer Risk Assessment Tool (BCRAT) for US-born Hispanic women, but higher risks in foreign-born women. In independent data from the Women's Health Initiative, the HRM was well calibrated for US-born women (observed/expected [O/E] ratio = 1.07, 95% confidence interval [CI] = 0.81 to 1.40), but seemed to overestimate risk in foreign-born women (O/E ratio = 0.66, 95% CI = 0.41 to 1.07). The AUC was 0.564 (95% CI = 0.485 to 0.644) for US-born and 0.625 (95% CI = 0.487 to 0.764) for foreign-born women. Conclusions: The HRM is the first absolute risk model that is based entirely on data specific to Hispanic women by nativity. Further studies in Hispanic women are warranted to evaluate its validity. Published by Oxford University Press 2016. This work is written by US Government employees and is in the public domain in the US.
Authors: Lois B Travis; Deirdre Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Eero Pukkala; Charles F Lynch; David Pee; Susan A Smith; Mars B Van't Veer; Timo Joensuu; Hans Storm; Marilyn Stovall; John D Boice; Ethel Gilbert; Mitchell H Gail Journal: J Natl Cancer Inst Date: 2005-10-05 Impact factor: 13.506
Authors: J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand Journal: J Natl Cancer Inst Date: 1999-09-15 Impact factor: 13.506
Authors: M H Gail; L A Brinton; D P Byar; D K Corle; S B Green; C Schairer; J J Mulvihill Journal: J Natl Cancer Inst Date: 1989-12-20 Impact factor: 13.506
Authors: Martha L Slattery; Carol Sweeney; Sandra Edwards; Jennifer Herrick; Kathy Baumgartner; Roger Wolff; Maureen Murtaugh; Richard Baumgartner; Anna Giuliano; Tim Byers Journal: Breast Cancer Res Treat Date: 2007-03 Impact factor: 4.872
Authors: Laura Fejerman; Mariana C Stern; Elad Ziv; Esther M John; Gabriela Torres-Mejia; Lisa M Hines; Roger Wolff; Wei Wang; Kathy B Baumgartner; Anna R Giuliano; Martha L Slattery Journal: Carcinogenesis Date: 2013-04-04 Impact factor: 4.944
Authors: Jeffrey A Tice; Steven R Cummings; Rebecca Smith-Bindman; Laura Ichikawa; William E Barlow; Karla Kerlikowske Journal: Ann Intern Med Date: 2008-03-04 Impact factor: 25.391
Authors: Matthew E Mealiffe; Renee P Stokowski; Brian K Rhees; Ross L Prentice; Mary Pettinger; David A Hinds Journal: J Natl Cancer Inst Date: 2010-10-18 Impact factor: 13.506
Authors: Anne Marie McCarthy; Brad Keller; Despina Kontos; Leigh Boghossian; Erin McGuire; Mirar Bristol; Jinbo Chen; Susan Domchek; Katrina Armstrong Journal: Breast Cancer Res Date: 2015-01-08 Impact factor: 6.466
Authors: Anne Marie McCarthy; Zoe Guan; Michaela Welch; Molly E Griffin; Dorothy A Sippo; Zhengyi Deng; Suzanne B Coopey; Ahmet Acar; Alan Semine; Giovanni Parmigiani; Danielle Braun; Kevin S Hughes Journal: J Natl Cancer Inst Date: 2020-05-01 Impact factor: 13.506
Authors: James Sun; Dung-Tsa Chen; Jiannong Li; Weihong Sun; Sean J Yoder; Tania E Mesa; Marek Wloch; Richard Roetzheim; Christine Laronga; M Catherine Lee Journal: J Surg Res Date: 2019-08-13 Impact factor: 2.192
Authors: Constance D Lehman; Sarah Mercaldo; Leslie R Lamb; Tari A King; Leif W Ellisen; Michelle Specht; Rulla M Tamimi Journal: J Natl Cancer Inst Date: 2022-10-06 Impact factor: 11.816
Authors: Amber N Hurson; Parichoy Pal Choudhury; Chi Gao; Anika Hüsing; Mikael Eriksson; Min Shi; Michael E Jones; D Gareth R Evans; Roger L Milne; Mia M Gaudet; Celine M Vachon; Daniel I Chasman; Douglas F Easton; Marjanka K Schmidt; Peter Kraft; Montserrat Garcia-Closas; Nilanjan Chatterjee Journal: Int J Epidemiol Date: 2021-03-23 Impact factor: 9.685
Authors: Michael C S Bissell; Karla Kerlikowske; Brian L Sprague; Jeffery A Tice; Charlotte C Gard; Katherine Y Tossas; Garth H Rauscher; Amy Trentham-Dietz; Louise M Henderson; Tracy Onega; Theresa H M Keegan; Diana L Miglioretti Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-07-29 Impact factor: 4.254
Authors: Carolyn Nickson; Pietro Procopio; Louiza S Velentzis; Sarah Carr; Lisa Devereux; Gregory Bruce Mann; Paul James; Grant Lee; Cameron Wellard; Ian Campbell Journal: Breast Cancer Res Date: 2018-12-20 Impact factor: 6.466
Authors: Marie E Wood; Nicholas H Farina; Thomas P Ahern; Melissa E Cuke; Janet L Stein; Gary S Stein; Jane B Lian Journal: Aging (Albany NY) Date: 2019-02-20 Impact factor: 5.682